DSM signs supply and licensing agreement with SpineVision
Mar 23, 2013 (Datamonitor via COMTEX) --
DSM, a provider of biomedical materials, has signed a supply and licensing agreement with SpineVision, a medical device company.
The agreement grants SpineVision the use of Bionate II PCU, a DSM polymer, in its new Flex+2 systems. The system is adaptable to the various stages of disc degeneration from early degeneration of intervertebral discs to total disc degeneration requiring fusion procedures.
"The combination of design changes and the use of Bionate II PCU have enabled SpineVision to enhance the mechanical capabilities of the new Flex+2 system leading to extended indications" said Arnaud Brisard, CEO, SpineVision.
"DSM's polyurethane materials have a proven clinical history and have been used in several dynamic stabilization devices and implants," said William Fuller, Director of Business Development, DSM Biomedical. "Our Bionate II PCU provides increased flexibility and shock absorbing characteristics, replicating the natural movements of the spine. We are proud to see Bionate II PCU contributing to the performance of SpineVision's Flex+2 system."
SpineVision will initially launch the Flex+2 systems in the European Union. The device is not currently available for sale in the US.
Republication or redistribution, including by framing or similar means,
is expressly prohibited without prior written consent. Datamonitor shall
not be liable for errors or delays in the content, or for any actions
taken in reliance thereon
[ Back To Technology News's Homepage ]